[Thromboembolic disease: prevention with low-molecular weight heparin in general surgery. Preliminary results].
Nine patients undergoing surgery lasting more than 45 minutes were included in the study. They received weekly anti-thromboembolic treatment with parnaparin (INN). Patients did not present thromboembolic complications following clinical and instrumental examination. Blood loss remained within the norm and no collateral effects were observed.
Pietrelli
F
F
Servizio di Anestesia, Rianimazione, USL n. 6, Ospedale Civile, Fossombrone, Pesaro.
Renzoni
T
T
Cicoli
C
C
D000368:Aged; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D006495:Heparin, Low-Molecular-Weight; C080945:parnaparin
La malattia tromboembolica: prevenzione con eparina a basso peso molecolare in chirurgia generale. Risultati preliminari.